Oxidative stress-cause or consequence of male genital tract disorders?

Prostate

Volumn 72, Issue 9, 2012, Pages 977-983

  Kullisaar, Tiiu ^a   Türk, Silver ^a   Punab, Margus ^b   Mändar, Reet ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

8 isoprostanes; asymptomatic inflammatory prostatitis; benign prostate hyperplasia; inflammatory chronic prostatitis chronic pelvic pain syndrome; non inflammatory chronic prostatitis chronic pelvic pain syndrome; oxidative stress

Indexed keywords

8 ISOPROSTANE;

ADULT; AGED; ARTICLE; CHRONIC PROSTATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATITIS; URINALYSIS; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; GENITAL DISEASES, MALE; HUMANS; INFERTILITY, MALE; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATITIS; YOUNG ADULT;

EID: 84861100842     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21502     Document Type: Article

References (43)

1. Kramer G, Marberger M,. Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 2006; 16: 25-29.
2. Sutcliffe S, Giovannucci E, De Marzo AM, Willett WC, Platz EA,. Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms. Am J Epidemiol 2005; 162: 898-906.
3. Kermes K, Punab M, Lõivukene K, Mändar R,. Anaerobic seminal fluid microflora in chronic prostatitis/chronic pelvic pain syndrome patients. Anaerobe 2003; 9: 117-123.
4. Nickel JC, Shoskes DA,. Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome. BJU Int 2010; 106: 1252-1263.
5. Krieger JN, Riley DE, Roberts MC, Berger RE,. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 1996; 34: 3120-3128.
6. Lee JC, Muller CH, Rothman I, Agnew KJ, Eschenbach D, Ciol MA, Turner JA, Berger RE,. Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 2003; 169: 584-587.
7. Robert G, Salagierski M, Schalken JA, de La Taille A,. Inflammation and benign prostatic hyperplasia: Cause or consequence? Prog Urol 2010; 20: 402-407.
8. Kramer G, Mitteregger D, Marberger M,. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 2007; 51: 1202-1216.
9. Roper WG,. The etiology of benign prostatic hypertrophy. Med Hypotheses 1998; 50: 61-65.
10. Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, Rittmaster RS,. The relationship between prostate inflammation and lower urinary tract symptoms: Examination of baseline data from the REDUCE trial. Eur Urol 2008; 54: 1379-1384.
11. Sciarra A, Mariotti G, Salciccia S, Gomez AA, Monti S, Toscano V, Di Silverio F,. Prostate growth and inflammation. J Steroid Biochem Mol Biol 2008; 108: 254-260.
12. Kullisaar T, Türk S, Punab M, Korrovits P, Kisand K, Rehema A, Zilmer K, Zilmer M, Mändar R,. Oxidative stress in leucocytospermic prostatitis patients: preliminary results. Andrologia 2008; 40 (3): 161-72.
13. Pace G, Di Massimo C, De Amicis D, Corbacelli C, Di Renzo L, Vicentini C, Miano L, Tozzi Ciancarelli MG,. Oxidative stress in benign prostatic hyperplasia and prostate cancer. Urol Int 2010; 85: 328-333.
14. Potts JM, Pasqualotto FF,. Seminal oxidative stress in patients with chronic prostatitis. Andrologia 2003; 35: 304-308.
15. World Health Organization. Laboratory manual for examination of human semen and sperm-cervical mucus interaction, 4th edition. New York: Cambridge University Press; 1999.
16. National Institutes of Health. National Institutes of Health Summary Statement. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Workshop on Chronic Prostatitis. Executive Summary. Bethesda, Maryland: NIH; 1995.
17. Kullisaar T, Songisepp E, Mikelsaar M, Zilmer K, Vihalemm T, Zilmer M,. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenecity in human subjects. Br J Nutr 2003; 90: 449-456.
18. Arisan ED, Arisan S, Kiremit MC, Tiǧli H, Caşkurlu T, Palavan-Unsal N, Ergenekon E,. Manganese superoxide dismutase polymorphism in chronic pelvic pain syndrome patients. Prostate Cancer Prostatic Dis 2006; 9: 426-431.
19. Mazzoli S,. Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 2010; 59: 337-344.
20. Montuschi P, Barnes P, Roberts LJ II., Insights into oxidative stress: The isoprostanes. Curr Med Chem 2007; 14: 703-717.
21. Krieger JN, Nyberg L, Nickel JC,. NIH consensus definition and classification of prostatitis. JAMA 1999; 282: 236-237.
22. Saleh RA, Agarwal A, Nada EA, El-Tonsy MH, Sharma RK, Meyer A, Nelson DR, Thomas AJ,. Negative effects of increased sperm DNA damage in relation to seminal oxidative stress in men with idiopathic and male factor infertility. Fertil Steril 2003; 79 (Suppl 3): 1597-605.
23. Korrovits P, Ausmees K, Mändar R, Punab M,. Prevalence of asymptomatic inflammatory (National Institutes of Health category IV) prostatitis in young men according to semen analysis. Urology 2008; 71: 1010-1015.
24. Schwartz ES, Kim HY, Wang J, Lee I, Klann E, Chung JM, Chung K,. Persistent pain is dependent on spinal mitochondrial antioxidant levels. J Neurosci 2009; 29: 159-168.
25. Nishimura T, Terashima Y, Hattori T, Satoh M, Yoshida K, Akimoto M,. Study of macrophages in prostatic fluid from nonbacterial prostatitis patients. V. Relation between activation of macrophages and stage of prostatitis. Urol Int 1991; 46: 15-17.
26. Little JW, Doyle T, Salvemini D,. Reactive nitroxidative species and nociceptive processing: Determining the roles for nitric oxide, superoxide, and peroxynitrite in pain. Amino Acids 2010. [Epub ahead of print]. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20552384.
27. Randall JM, Evans DH, Bird VG, Aballa TC, Lynne CM, Brackett NL,. Leukocytospermia in spinal cord injured patients is not related to histological inflammatory changes in the prostate. J Urol 2003; 170: 897-900.
28. Meyer-Siegler KL, Vera PL,. Intraluminal antibodies to macrophage migration inhibitory factor decrease substance P induced inflammatory changes in the rat bladder and prostate. J Urol 2004; 172: 1504-1509.
29. Chen Y, Wu X, Liu J, Tang W, Zhao T, Zhang J,. Distribution of convergent afferents innervating bladder and prostate at dorsal root Ganglia in rats. Urology 2010; 76: 764.e1-764.e6.
30. Anand U, Otto WR, Facer P, Zebda N, Selmer I, Gunthorpe MJ, Chessell IP, Sinisi M, Birch R, Anand P,. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons. Neurosci Lett 2008; 438: 221-227.
31. Kosugi M, Nakatsuka T, Fujita T, Kuroda Y, Kumamoto E,. Activation of TRPA1 channel facilitates excitatory synaptic transmission in substantia gelatinosa neurons of the adult rat spinal cord. J Neurosci 2007; 27: 4443-4451.
32. Uta D, Furue H, Pickering AE, Rashid MH, Mizuguchi-Takase H, Katafuchi T, Imoto K, Yoshimura M,. TRPA1-expressing primary afferents synapse with a morphologically identified subclass of substantia gelatinosa neurons in the adult rat spinal cord. Eur J Neurosci 2010; 31: 1960-1973.
33. Taylor-Clark TE, McAlexander MA, Nassenstein C, Sheardown SA, Wilson S, Thornton J, Carr MJ, Undem BJ,. Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal. J Physiol 2008; 586: 3447-3459.
34. Taylor-Clark TE, Undem BJ, Macglashan DW Jr, Ghatta S, Carr MJ, McAlexander MA,. Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1). Mol Pharmacol 2008; 73: 274-281.
35. Malykhina AP,. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience 2007; 149: 660-672.
36. Tarcan T, Siroky MB, Krane RJ, Azadzoi KM,. Isoprostane 8-epi PGF2α, a product of oxidative stress, is synthesized in the bladder and causes detrusor smooth muscle contraction. Neurourol Urodyn 2000; 19: 43-51.
37. Pontari AM,. Inflammation and anti-inflammatory therapy in chronic prostatitis. Urology 2002; 60: 29-33.
38. Matsumoto S, Hanai T, Matsui T, Oka M, Tanaka M, Uemura H,. Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia. Phytother Res 2010; 24: 301-303.
39. Oner-Iyidoǧan Y, Koçak H, Gürdöl F, Koçak T, Erol B,. Urine 8-isoprostane F2alpha concentrations in patients with neurogenic bladder due to spinal cord injury. Clin Chim Acta 2004; 339: 43-47.
40. Leimgruber C, Quintar AA, Sosa LD, García LN, Figueredo M, Maldonado CA,. Dedifferentiation of prostate smooth muscle cells in response to bacterial LPS. Prostate 2011; 71: 1097-1107.
41. Gatti G, Rivero V, Motrich RD, Maccioni M,. Prostate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulation. J Leukoc Biol 2006; 79: 989-998.
42. Fassi Fehri L, Mak TN, Laube B, Brinkmann V, Ogilvie LA, Mollenkopf H, Lein M, Schmidt T, Meyer TF, Brüggemann H,. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Int J Med Microbiol 2011; 301: 69-78.
43. Karatas OF, Bayrak O, Cimentepe E, Unal D,. An insidious risk factor for cardiovascular disease: Benign prostatic hyperplasia. Int J Cardiol 2010; 144: 452.